In August of 2020, Betalin Therapeutics opened a subsidiary, BetalinUK, in Leeds, United Kingdom. This new adventure brings an exciting opportunity to work with key clinicians and scientists to help us accelerate into our first-in-man studies
BetalinUK is a member of the Northern Alliance Advance Therapies Treatment Centre (NA-ATTC, compromising of Edinburgh, Glasgow, Leeds and Newcastle) which aims to introduce new technologies in the field of cell and gene therapies, and to increase patient access to advanced therapy medicinal products (ATMPs) on a national level
What's in the pipeline for BetalinUK?
BetalinUK works closely with both Newcastle University and the Univeristy of Leeds. We will be looking to expand our teams with exceptional scientists, more information about current vacancies will be announced soon.